D5 dopamine receptor carboxyl tail involved in D5-D2 heteromer formation.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2013-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbrc.2012.12.139PMID 23318175PMCID PMC3744868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation.

  2012cited by this paper
• Disruption of the mu-delta opioid receptor heteromer.

  2012cited by this paper
• Separation and reformation of cell surface dopamine receptor oligomers visualized in cells.

  2011cited by this paper
• The Dopamine D1-D2 Receptor Heteromer Localizes in Dynorphin/Enkephalin Neurons

  2010cited by this paper
• G protein-coupled receptor oligomerization for what?

  2010cited by this paper
• Calcium Signaling by Dopamine D5 Receptor and D5-D2 Receptor Hetero-Oligomers Occurs by a Mechanism Distinct from That for Dopamine D1-D2 Receptor Hetero-Oligomers

  2009cited by this paper
• Calcium signaling cascade links dopamine D1–D2 receptor heteromer to striatal BDNF production and neuronal growth

  2009cited by this paper
• THEMED ISSUE: GPCR REVIEW G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function

  2009cited by this paper
• Using Ligand-Induced Conformational Change to Screen for Compounds Targeting G-Protein-Coupled Receptors

  2007cited by this paper
• Dopamine Receptor Oligomerization Visualized in Living Cells*

  2005cited by this paper
• G-Protein-coupled receptor oligomerization and its potential for drug discovery

  2002cited by this paper

• GPCR Heterodimers: Implications for Biased Signaling.

  2025cites this paper
• Chemokinergic and Dopaminergic Signalling Collaborates through the Heteromer Formed by CCR9 and Dopamine Receptor D5 Increasing the Migratory Speed of Effector CD4+ T-Cells to Infiltrate the Colonic Mucosa

  2024cites this paper
• The World of GPCR dimers – Mapping dopamine receptor D2 homodimers in different activation states and configuration arrangements

  2023cites this paper
• Metamodulation of presynaptic NMDA receptors: New perspectives for pharmacological interventions.

  2023cites this paper
• Class A and C GPCR Dimers in Neurodegenerative Diseases

  2022cites this paper
• Journey from responsible alcohol drinking to alcoholism

  2021cites this paper
• Transcriptional signatures in prefrontal cortex confer vulnerability versus resilience to food and cocaine addiction-like behavior

  2021cites this paper
• Rules of amino acid convergence: Not how many, but who in avian vocal learning clades

  2020cites this paper
• Distinct Dopamine D2 Receptor Antagonists Differentially Impact D2 Receptor Oligomerization

  2019cites this paper
• Noncanonical Neurotransmitter Activation of Catecholamine Receptors

  2017cites this paper
• Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity.

  2017cites this paper
• Extreme Vetting of Dopamine Receptor Oligomerization

  2017cites this paper
• The Conserved Arginine Cluster in the Insert of the Third Cytoplasmic Loop of the Long Form of the D2 Dopamine Receptor (D2L-R) Acts as an Intracellular Retention Signal

  2016cites this paper
• Structure-guided development of heterodimer-selective GPCR ligands

  2016cites this paper
• Hypothetical orchestrated cooperation between dopaminergic and kinin receptors for the regulation of common functions.

  2016cites this paper
• The triplet puzzle theory indicates extensive formation of heteromers between opioid and chemokine receptor subtypes

  2015cites this paper
• Novel dimensions of D3 receptor function: Focus on heterodimerisation, transactivation and allosteric modulation.

  2015cites this paper
• A peptide targeting an interaction interface disrupts the dopamine D1‐D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism

  2014cites this paper
• Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance

  2014cites this paper
• G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives

  2014cites this paper
• Computational approaches for modeling GPCR dimerization.

  2014cites this paper
• Intranasal Delivery of a Peptide with Antidepressant-Like Effect

  2014cites this paper